These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 37987149)
1. Overview of Determination of Biopharmaceutical Properties for Development Candidate Selection. Yazdanian M Curr Protoc; 2023 Nov; 3(11):e926. PubMed ID: 37987149 [TBL] [Abstract][Full Text] [Related]
2. Overview of determination of biopharmaceutical properties for development candidate selection. Yazdanian M Curr Protoc Pharmacol; 2013 Mar; Chapter 9():Unit9.17. PubMed ID: 23456615 [TBL] [Abstract][Full Text] [Related]
3. In vitro models for the prediction of in vivo performance of oral dosage forms. Kostewicz ES; Abrahamsson B; Brewster M; Brouwers J; Butler J; Carlert S; Dickinson PA; Dressman J; Holm R; Klein S; Mann J; McAllister M; Minekus M; Muenster U; Müllertz A; Verwei M; Vertzoni M; Weitschies W; Augustijns P Eur J Pharm Sci; 2014 Jun; 57():342-66. PubMed ID: 23988843 [TBL] [Abstract][Full Text] [Related]
4. Selecting oral bioavailability enhancing formulations during drug discovery and development. Leucuta SE Expert Opin Drug Discov; 2014 Feb; 9(2):139-50. PubMed ID: 24387781 [TBL] [Abstract][Full Text] [Related]
5. Best practices in current models mimicking drug permeability in the gastrointestinal tract - An UNGAP review. O'Shea JP; Augustijns P; Brandl M; Brayden DJ; Brouwers J; Griffin BT; Holm R; Jacobsen AC; Lennernäs H; Vinarov Z; O'Driscoll CM Eur J Pharm Sci; 2022 Mar; 170():106098. PubMed ID: 34954051 [TBL] [Abstract][Full Text] [Related]
6. Modeling gastrointestinal drug absorption requires more in vivo biopharmaceutical data: experience from in vivo dissolution and permeability studies in humans. Lennernäs H Curr Drug Metab; 2007 Oct; 8(7):645-57. PubMed ID: 17979653 [TBL] [Abstract][Full Text] [Related]
7. Regional intestinal drug permeation: biopharmaceutics and drug development. Lennernäs H Eur J Pharm Sci; 2014 Jun; 57():333-41. PubMed ID: 23988845 [TBL] [Abstract][Full Text] [Related]
8. Physicochemical properties, form, and formulation selection strategy for a biopharmaceutical classification system class II preclinical drug candidate. Lohani S; Cooper H; Jin X; Nissley BP; Manser K; Rakes LH; Cummings JJ; Fauty SE; Bak A J Pharm Sci; 2014 Oct; 103(10):3007-21. PubMed ID: 25074668 [TBL] [Abstract][Full Text] [Related]
9. PBPK models for the prediction of in vivo performance of oral dosage forms. Kostewicz ES; Aarons L; Bergstrand M; Bolger MB; Galetin A; Hatley O; Jamei M; Lloyd R; Pepin X; Rostami-Hodjegan A; Sjögren E; Tannergren C; Turner DB; Wagner C; Weitschies W; Dressman J Eur J Pharm Sci; 2014 Jun; 57():300-21. PubMed ID: 24060672 [TBL] [Abstract][Full Text] [Related]
10. Analytical tools for the physicochemical profiling of drug candidates to predict absorption/distribution. Henchoz Y; Bard B; Guillarme D; Carrupt PA; Veuthey JL; Martel S Anal Bioanal Chem; 2009 Jun; 394(3):707-29. PubMed ID: 19184676 [TBL] [Abstract][Full Text] [Related]
11. Physicochemical profiling (solubility, permeability and charge state). Avdeef A Curr Top Med Chem; 2001 Sep; 1(4):277-351. PubMed ID: 11899112 [TBL] [Abstract][Full Text] [Related]
12. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim. Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464 [TBL] [Abstract][Full Text] [Related]
13. Provisional classification and in silico study of biopharmaceutical system based on caco-2 cell permeability and dose number. Pham-The H; Garrigues T; Bermejo M; González-Álvarez I; Monteagudo MC; Cabrera-Pérez MÁ Mol Pharm; 2013 Jun; 10(6):2445-61. PubMed ID: 23675957 [TBL] [Abstract][Full Text] [Related]
14. A modified physiological BCS for prediction of intestinal absorption in drug discovery. Zaki NM; Artursson P; Bergström CA Mol Pharm; 2010 Oct; 7(5):1478-87. PubMed ID: 20734997 [TBL] [Abstract][Full Text] [Related]
15. PAMAM Dendrimers: A Review of Methodologies Employed in Biopharmaceutical Classification. Guizze F; Serra CHR; Giarolla J J Pharm Sci; 2022 Oct; 111(10):2662-2673. PubMed ID: 35850238 [TBL] [Abstract][Full Text] [Related]
16. Trends in small molecule drug properties: A developability molecule assessment perspective. Agarwal P; Huckle J; Newman J; Reid DL Drug Discov Today; 2022 Dec; 27(12):103366. PubMed ID: 36122862 [TBL] [Abstract][Full Text] [Related]
17. Solubility and permeability measurement and applications in drug discovery. Burton PS; Goodwin JT Comb Chem High Throughput Screen; 2010 Feb; 13(2):101-11. PubMed ID: 20053165 [TBL] [Abstract][Full Text] [Related]
18. Prediction of solubility and permeability class membership: provisional BCS classification of the world's top oral drugs. Dahan A; Miller JM; Amidon GL AAPS J; 2009 Dec; 11(4):740-6. PubMed ID: 19876745 [TBL] [Abstract][Full Text] [Related]
19. An in vitro toolbox to accelerate anti-malarial drug discovery and development. Charman SA; Andreu A; Barker H; Blundell S; Campbell A; Campbell M; Chen G; Chiu FCK; Crighton E; Katneni K; Morizzi J; Patil R; Pham T; Ryan E; Saunders J; Shackleford DM; White KL; Almond L; Dickins M; Smith DA; Moehrle JJ; Burrows JN; Abla N Malar J; 2020 Jan; 19(1):1. PubMed ID: 31898492 [TBL] [Abstract][Full Text] [Related]
20. The Biopharmaceutics Classification System: subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC. Tsume Y; Mudie DM; Langguth P; Amidon GE; Amidon GL Eur J Pharm Sci; 2014 Jun; 57():152-63. PubMed ID: 24486482 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]